Conferences on June 12, 2012

The Neutrophil in Immunity

Date: 09-Jun-12 to 12-Jun-12
Location: Quebec / Canada
This will be the first scientific conference ever held that focuses solely on neutrophil leukocytes and their important role in immunity. Several aspects of the program will be of interest to the pharmaceutical and biotechnology industry

Global Pharma Manufacturing Summit 2012

Date: 11-Jun-12 to 12-Jun-12
Location: New York / United States
Now in its seventh year, the Global Pharma Manufacturing Summit has grown into the premier networking opportunity for industry leaders involved in small molecule and biologic pharma manufacturing. Senior executives and decision-makers from across the pharmaceutical industry will spend two days this June discussing solutions to the universal challenges facing every organization in the current age of transition and austerity.

Air Mission Planning

Date: 11-Jun-12 to 12-Jun-12
Location: London / United Kingdom
SMi Group proudly presents the 3rd annual Air Mission Planning conference, which will be held in London on 11th & 12th June 2012. From tasking to re-tasking, mission planning is the core competence that underpins air operations for our flight crews and airmen. Advances in technology have increased capability and safety in the air whilst the evolution to dynamic mission planning has been supported by the modern tools at our disposal over the last two decades. In the 21st century, mission planning equipment must now work in partnership with the rest of an aircraft’s avionics suite to establish air superiority. Defence against cruise missiles, managing Beyond Visual Range and Within Visual Range engagements and the ability of UAVs to cooperate with manned platforms in theatre all ...

FDA Warning Letter Closeout Program

Date: 12-Jun-12 to 12-Jun-12
This FDA warning letter closeout program will discuss how to successfully complete warning letter close out program which will help firm to obtain a closeout letter from FDA. Why Should You Attend: FDA Commissioner Margaret Hamburg recently announced several new enforcement initiatives. Part of the "new FDA" is the increased issuance of warning letters and the creation of a warning letter "closeout", which regulated firms can use to your advantage. FDA's warning letter program has changed substantially and more warning letters will be issued - and faster! In the past, firms that received a warning letter from FDA were subject to unending scrutiny, speculation and financial challenge. But now warning letter recipients will have the chance to prove they are back in ...

Residual Moisture Testing of Lyophilized Products - Webinar By GlobalCompliancePanel

Date: 12-Jun-12 to 12-Jun-12
Overview: This webinar will cover the various methods used to determine residual moisture in products ranging from bulk powders, to sterile freeze-died products in vials, to foods. Understanding the different techniques, their limitations, and proper execution will result in more accurate and precise moisture results, which translates into better quality products with longer shelf lives. Why you should attend: Monitoring and controlling residual moisture in powders, lyophilized solids, foods, etc can be a critical factor in achieving and maintaining quality products throughout their expected shelf life. Improper levels of moisture in products can result in poor powder flow properties, spoilage, polymorph changes, changes in compaction properties, microorganism growth promotion, higher ...

Medical Device Postmarketing Vigilance Reporting: Update and Expectations for Manufacturers - Webinar By GlobalCompliancePanel

Date: 12-Jun-12 to 12-Jun-12
Overview: Major postmarketing vigilance revisions are now in force. A revised medical device guidance document on postmarketing vigilance (MEDDEV 2.12-1 rev 5) came into force on January 1, 2008. Providing more guidance than the previous version, the new document includes new reporting terminology and concepts such as "periodic summary reporting" and "trend reporting." In addition, the terms "advisory notice," "near incident," and "recall" have been eliminated or replaced. Although MEDDEVs are not legally binding, it is likely that all European Competent Authorities will follow the new guidelines and will expect organizations involved in the management and reporting of adverse incidents to follow them as well. This session will address ...

Management Controls Under QSR and ISO 13485 - Webinar By GlobalCompliancePanel

Date: 12-Jun-12 to 12-Jun-12
Overview: The top management of a company is responsible for ensuring that all regulatory requirements are met. This concept is codified in both the QSR and ISO 13485. FDA officials have repeatedly stated that the management controls subsystem is the central subsystem because it is the "glue that holds the quality system together." Since it is individuals in top management that the FDA will typically seek to fine or prosecute in the event of major noncompliance, this session is key for those individuals who are members of top management, or those regulatory professionals who need to understand these requirements to assure top management is fulfilling its responsibilities. This session will discuss the requirements for Management Controls, including organizational structure, ...

TECHEXPO Top Secret Hiring Event

Date: 12-Jun-12 to 12-Jun-12
Explore new career opportunities this June! Bring many resumes and interview for the many opportunities available in cyber security, information technology, engineering, aerospace, telecom, project management, intelligence, operations, homeland security, research & more at TECHEXPO Top Secret's June hiring events! Tuesday, June 12th • 10am - 3pm BWI Marriott 1743 West Nursery Road Baltimore, MD 21090 Directions Only: 410.859.8300 Pre-Register: www.TECHEXPOUSA.com

Advanced Interviewing - How to Eliminate Candidate Embellishment -Webinar By TrainHR

Date: 12-Jun-12 to 12-Jun-12
Overview : Are your managers making some of the most common problems that occur in typical interviews? Hiring managers succumb to first impressions and lack objectivity in the interview process. Candidates have multiple interviews, but in reality the same basic questions are asked over and over again. The questions used by hiring managers are either so far off the mark in terms of being valuable in assessing candidates, they border on comedy, or they are canned questions that solicit meaningless canned answers from the candidate. There is no common framework among the interviewing committee or group of hiring managers in assessing the candidate. Your interviewers are asking the same questions they were asked when they were hired. The person who interviews ...

Practical Issues with Conducting Multi-National Clinical Trials for Medical Device Approval in the US

Date: 12-Jun-12 to 12-Jun-12
This webinar will cover essential elements of multi-national medical device clinical trials, help you understand US and non-US regulatory processes for medical device clinical trials and provide practical tips for assuring US market approval for your device.